Medopad
Allows doctors to access and analyse patients' data
Medopad has raised €48M across 5 funding rounds from 3 investors, most recently a Series B round in Oct 2019. Based in London, UK; founded 2011; active in Software and Healthtech. Data as of 28 Oct 2026.
Total raised
€48M
€48,243,721
Funding rounds
5
Investors
3
distinct backers
Active since
2012-01
latest 2019-10
Funding by year
EUR raised per yearMedopad — funding by year — interactive chart.
Data table
| Medopad — funding by year | |
|---|---|
| 2011 | €1.0M |
| 2013 | €900k |
| 2014 | €507k |
| 2017 | €23M |
| 2019 | €23M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 5 rounds raised
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series B | €23M | Bayer | View deal → |
| 2018-01-01 | Other | €23M | NWS Holdings | View deal → |
| 2014-03-01 | Seed | €507k | Vodafone | View deal → |
| 2013-06-01 | Other | €900k | — | View deal → |
| 2012-01-01 | Other | €1.0M | — | View deal → |